HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dapsone syndrome in cutaneous lupus erythematosus.

Abstract
Dapsone is increasingly used in the treatment of rheumatic diseases. It is indicated in many inflammatory skin conditions characterized by polymorphonuclear cell infiltration. Minor reactions to the drug are very common, but severe idiosyncratic reactions are rare considering the large number of patients taking this drug worldwide. We describe 2 patients with cutaneous lupus erythematosus who developed severe dapsone reaction after low dose therapy, with a fatal outcome in one. Physicians should be aware of the potentially lethal side effects of dapsone.
AuthorsC C Mok, C S Lau
JournalThe Journal of rheumatology (J Rheumatol) Vol. 23 Issue 4 Pg. 766-8 (Apr 1996) ISSN: 0315-162X [Print] Canada
PMID8730143 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Leprostatic Agents
  • Dapsone
Topics
  • Adult
  • Dapsone (adverse effects)
  • Fatal Outcome
  • Female
  • Humans
  • Leprostatic Agents (adverse effects)
  • Lupus Erythematosus, Cutaneous (drug therapy, pathology)
  • Male
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: